Genscript Biotech Corporation
HKSE: 1548.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Weihui Shao
- Employees
- 5,568
- Headquarters
- Nanjing, China
- IPO year
- 2015
- Market cap
- HK$33.2B
- Website
- https://www.genscript.com
Loading 1548…
Loading profile data…Frequently asked questions about 1548
What does Genscript Biotech Corporation (1548.HK) do?
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in North America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. It operates through four segments: Life Science Services and Products, Biologics Dev...
Where does 1548.HK trade?
Genscript Biotech Corporation (1548.HK) trades on the Hong Kong Stock Exchange.
What sector is 1548.HK in?
Genscript Biotech Corporation (1548.HK) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Genscript Biotech Corporation?
Weihui Shao is the chief executive officer of Genscript Biotech Corporation (1548.HK).
Where is Genscript Biotech Corporation headquartered?
Genscript Biotech Corporation is headquartered in China.
Does 1548.HK pay a dividend?
Genscript Biotech Corporation (1548.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 1548.HK go public?
Genscript Biotech Corporation (1548.HK) completed its initial public offering in 2015.